Target intelligence / Profile preview

Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10)

Target
SIGLEC10
Molecular classification
Immunoglobulin superfamily, I-type lectin, Receptor
01

Overview

Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10) is an inhibitory receptor primarily expressed on cells of the innate immune system such as eosinophils, neutrophils, monocytes, and B cells. It belongs to the immunoglobulin superfamily and contains an N-terminal Ig-like V-type domain responsible for sialic acid binding, followed by four Ig-like C2-type domains, a transmembrane segment, and a cytoplasmic domain with two ITIMs. SIGLEC10 interacts with sialylated proteins and lipids, including CD52, CD24, and VAP‑1, modulating immune responses and potentially playing a role in tumor immune evasion.

Other names
PRO940SIGLEC-10SLG2sialic acid binding Ig like lectin 10
02

Mechanism of action

ITIM-mediated recruitment of phosphatases to dampen cellular activation signals.

03

Biological functions

Inhibitory signalingRegulation of autoimmunityModulation of inflammation
04

Disease associations

AutoimmunityInflammationCancer
05

Safety considerations

Potential role in tumor immune evasion
06

Interacting drugs

Alemtuzumab
07

Biomarkers

Siglec-10 expression level in hepatocellular carcinoma patients

Beyond the preview

Go deeper on Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid-binding immunoglobulin-like lectin 10 (SIGLEC10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call